English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  51807424    在线人数 :  929
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"liu w c"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 321-330 / 549 (共55页)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-09-30T03:22:21Z Performance of fracture risk assessment tool in HIV-positive male individuals aged ?45?years on suppressive antiretroviral therapy Tsai M.-S.; Zhang J.-Y.; Sun H.-Y.; Liu W.-C.; Wu P.-Y.; Yang C.-J.; CHIEN-CHING HUNG; Tsai M.-S.;Zhang J.-Y.;Sun H.-Y.;Liu W.-C.;Wu P.-Y.;Yang C.-J.;Chien-Ching Hung
臺大學術典藏 2020-09-30T03:22:19Z Effectiveness of switching from protease inhibitors to dolutegravir in combination with nucleoside reverse transcriptase inhibitors as maintenance antiretroviral therapy among HIV-positive patients Liu W.-C.; CHIEN-CHING HUNG; Huang Y.-C.; Su Y.-C.; Chen G.-J.;Sun H.-Y.;Chang S.-Y.;Cheng A.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Chen G.-J.; Sun H.-Y.; Chang S.-Y.; Cheng A.; Huang Y.-S.; Lin K.-Y.
臺大學術典藏 2020-09-30T03:22:19Z Risk of elevation of serum creatine kinase among HIV-positive individuals receiving dolutegravir-based combination antiretroviral therapy Chen G.-J.;Sun H.-Y.;Cheng A.;Chuang Y.-C.;Huang Y.-S.;Lin K.-Y.;Huang Y.-C.;Liu W.-C.;Wu P.-Y.;Chien-Ching Hung;Chang S.-C.; Chen G.-J.; Sun H.-Y.; Cheng A.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang Y.-C.; Liu W.-C.; Wu P.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:19Z Long-term virological and serologic responses of chronic hepatitis B virus infection to tenofovir disoproxil fumarate-containing regimens in patients with HIV and hepatitis B coinfection Huang Y.-S.;Sun H.-Y.;Chang S.-Y.;Chuang Y.-C.;Cheng A.;Huang S.-H.;Huang Y.-C.;Chen G.-J.;Lin K.-Y.;Su Y.-C.;Liu W.-C.;Chien-Ching Hung; Huang Y.-S.; Sun H.-Y.; Chang S.-Y.; Chuang Y.-C.; Cheng A.; Huang S.-H.; Huang Y.-C.; Chen G.-J.; Lin K.-Y.; Su Y.-C.; Liu W.-C.; CHIEN-CHING HUNG
臺大學術典藏 2020-09-30T03:22:18Z Short-term outcomes of rapid initiation of antiretroviral therapy among HIV-positive patients: Real-world experience from a single-centre retrospective cohort in Taiwan Huang Y.-C.; Sun H.-Y.; Chuang Y.-C.; Huang Y.-S.; Lin K.-Y.; Huang S.-H.; Chen G.-J.; Luo Y.-Z.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:17Z Hepatitis E Virus Infections Among Human Immunodeficiency Virus–Positive Individuals During an Outbreak of Acute Hepatitis A in Taiwan Chang S.-Y.; Liu W.-C.; Lin K.-Y.; Lin P.-H.; Sun H.-Y.; Chen Y.-T.; Su L.-H.; Su Y.-C.; Ho S.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:17Z HCV reinfections after viral clearance among HIV-positive patients with recent HCV infection in Taiwan Huang M.-H.;Chang S.-Y.;Liu C.-H.;Cheng A.;Su L.-H.;Liu W.-C.;Su Y.-C.;Sun H.-Y.;Chien-Ching Hung;Chang S.-C.; Huang M.-H.; Chang S.-Y.; Liu C.-H.; Cheng A.; Su L.-H.; Liu W.-C.; Su Y.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Chang S.-C.
臺大學術典藏 2020-09-30T03:22:16Z Effectiveness of half-a-tablet efavirenz plus 2 nucleos(t)ide reverse-transcriptase inhibitors as maintenance therapy with the guidance of therapeutic drug monitoring among virologically suppressed HIV-positive patients: A prospective study Huang S.-H.; Lin S.-W.; Chang S.-Y.; Lin Y.-T.; Sun H.-Y.; Liu W.-C.; Su Y.-C.; CHIEN-CHING HUNG; Chang S.-C.; Huang S.-H.;Lin S.-W.;Chang S.-Y.;Lin Y.-T.;Sun H.-Y.;Liu W.-C.;Su Y.-C.;Chien-Ching Hung;Chang S.-C.
臺大學術典藏 2020-09-30T03:22:16Z Therapeutic drug monitoring study on the switch from coformulated 600-mg efavirenz, tenofovir disoproxil fumarate, and emtricitabine to coformulated 400-mg efavirenz, tenofovir disoproxil fumarate, and lamivudine among HIV-positive patients with viral suppression Chen Y.-T.; Chen Y.-W.; Chang S.-Y.; Liu W.-C.; Sun H.-Y.; CHIEN-CHING HUNG; Ou S.-T.; Lin S.-W.; Huang W.-C.;Huang C.-K.;Huang S.-H.;Lin S.-W.;Ou S.-T.;Chen Y.-T.;Chen Y.-W.;Chang S.-Y.;Liu W.-C.;Sun H.-Y.;Chien-Ching Hung; Huang W.-C.; Huang C.-K.; Huang S.-H.
臺大學術典藏 2020-09-30T03:22:15Z Weight gain and dyslipidemia among virally suppressed HIV-positive patients switching to co-formulated elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide Kuo P.-H.;Sun H.-Y.;Chuang Y.-C.;Wu P.-Y.;Liu W.-C.;Chien-Ching Hung; Kuo P.-H.; Sun H.-Y.; Chuang Y.-C.; Wu P.-Y.; Liu W.-C.; CHIEN-CHING HUNG

显示项目 321-330 / 549 (共55页)
<< < 28 29 30 31 32 33 34 35 36 37 > >>
每页显示[10|25|50]项目